Trials / Unknown
UnknownNCT04504890
Ocular-vestibular Biomarker Identification for ADHD
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 240 (estimated)
- Sponsor
- Sync-Think, Inc. · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
This study intends to establish a relationship between oculovestibular eye tracking measures, measures of ADHD, and medication prescribed for ADHD.
Detailed description
This study will use a predictive visual tracking paradigm (SyncThink EYE-SYNC eye tracking paradigm) to dynamically capture the participants' attentional state. It will examine the validity of the eye tracking paradigm in identifying the disruption in attentional networks caused by ADHD by examining the association between eye tracking performances and well-established standardized measures of ADHD.
Conditions
- ADHD - Combined Type
- ADHD
- ADHD Predominantly Inattentive Type
- ADHD, Predominantly Hyperactive - Impulsive
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | EYE-SYNC | Nystagmograph used to measure eye movement |
Timeline
- Start date
- 2020-07-16
- Primary completion
- 2021-08-05
- Completion
- 2021-10-05
- First posted
- 2020-08-07
- Last updated
- 2020-10-23
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04504890. Inclusion in this directory is not an endorsement.